The Zenith Drugs IPO started on February 19, 2024, and ended on February 22, 2024. Shares were allocated on February 23, 2024, and refund processes began on February 26, 2024. On February 26, 2024, the shares were credited to investors demat accounts. Zenith Drugs was officially listed on the stock exchange on February 27, 2024.
During the IPO, Zenith Drugs offered shares at a price range of ₹75 to ₹79 per share, and the lot size was 1600 shares. The total issue size was ₹40.68 crores, with ₹40.68 crores from new shares. The IPO was listed on both the NSE and BSE SME.
Regarding share reservations, 50% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 35% were set aside for retail investors.
Zenith Drugs IPO Subscription Update Video
Zenith Drugs IPO Subscription Status
The Zenith Drugs IPO on February 22, 2024 was subscribed 179.18 times, with the retail category being subscribed 139.28 times, the NII (Non-Institutional Investor) category being subscribed 368.77 times, the QIB (Qualified-Institutional Buyers) category being subscribed 106.72 times.
| Category | Subscription |
| QIB | 106.72x |
| NII | 368.77x |
| Retail | 139.28x |
| Total | 179.18x |
Zenith Drugs IPO Basic Details
| Company Name | Zenith Drugs Limited |
| Domain of Company | Pharma Company |
| Zenith Drugs IPO Open Date | February 19, 2024 |
| Zenith Drugs IPO Close Date | February 22, 2024 |
| Zenith Drugs IPO Allotment Date | February 23, 2024 |
| Zenith Drugs IPO Listing Date | February 27, 2024 |
| Face Value | ₹10 per share |
| Price | ₹75 to ₹79 per share |
| Lot Size | 1600 Shares |
| Issue Size | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Fresh Issue | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi |
About Zenith Drugs Limited
Established in the year 2000, Zenith Drugs Limited is a pharmaceutical company that focuses on creating and selling high-quality and affordable medicines, particularly generic drugs.
Committed to maintaining top-notch quality, the company follows WHO-GMP guidelines and has earned the ISO 9001:2015 certification from a reputable EuroUK certification body.
Zenith Drugs Limited offers a diverse range of products, including ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. With approval from the Food & Drugs Administration, the company currently has over 600 approved products, with 325 actively in production.
Currently, the company is in the process of establishing a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
Zenith Drugs Limited extends its product supply to various countries, including Costa Rica in Central America and the Caribbean, as well as Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
Specializing in third-party manufacturing, also known as white label manufacturing, Zenith Drugs Limited collaborates with esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma.
As of March 31, 2023, the company has a dedicated team of 89 employees, with 61 on the payroll and 28 on contract.
Zenith Drugs IPO Should you subscribe?
Zenith Drugs IPO More Details Click Here
Zenith Drugs IPO FAQs
What is the start and end date of Zenith Drugs IPO Subscription?
The Zenith Drugs IPO started on February 19, 2024, and ended on February 22, 2024.
When does Zenith Drugs IPO Subscription open?
The Zenith Drugs IPO open on February 19, 2024.
When does Zenith Drugs IPO Subscription close?
The Zenith Drugs IPO Close on February 22, 2024.
What is the allotment date of Zenith Drugs IPO?
The allotment date for Zenith Drugs IPO is February 23, 2024.
When is the initial refund date of Zenith Drugs IPO?
The initial Refund date for Zenith Drugs IPO is February 26, 2024.
When were the shares credited to investors demat accounts for the Zenith Drugs IPO?
The shares for the Zenith Drugs IPO were credited to investors demat accounts on February 26, 2024.
When will Zenith Drugs IPO be listed on the stock market?
Zenith Drugs IPO stock market will be listed on February 27, 2024 at 10 am.
What was the price range of the Zenith Drugs IPO shares?
The Zenith Drugs IPO shares were offered at a price range of ₹75 to ₹79 per share.
What was the lot size for the Zenith Drugs IPO shares?
The lot size for the Zenith Drugs IPO shares was 1600 shares.
What was the total issue size of the Zenith Drugs IPO?
The total issue size of the Zenith Drugs IPO was ₹40.68 crores.
How were the shares allocated among different types of investors for the Zenith Drugs IPO?
50% of the shares were allocated to Qualified Institutional Buyers (QIB), 15% were reserved for Non-Institutional Investors (NII), and 35% were set aside for retail investors.
On which stock exchanges was the Zenith Drugs IPO listed?
The Zenith Drugs IPO was listed on the NSE SME.
What is the Zenith Drugs IPO Subscription Status?
Zenith Drugs IPO is subscribed 179.18 Times.
